SREBF2-ACOT7轴促进瘤进展,并预测扩散大b细胞淋巴瘤的预后
Huan Wang1,2, Xiaowei Yao2, Shujun Wu1
1Department of respiratory, The first affiliated hospital of Zhengzhou University, Zhengzhou, 450000, Henan, China.
Scientific reports
|December 7, 2025
概括
乙-CoA thioesterase 7 (ACOT7) 在扩散性大B细胞淋巴瘤 (DLBCL) 中高度表达,促进瘤生长和入侵. 针对SREBF2-ACOT7通路可能为DLBCL患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的非霍奇金淋巴瘤,很大一部分患者出现复发或对标准R-CHOP疗法产生抵抗.
- 乙烯基-CoA硫酶 (ACOT) 家族成员影响脂质代谢,炎症和癌症,但ACOT7在DLBCL中的作用尚不清楚.
研究的目的:
- 研究DLBCL中ACOT7的表达和功能作用.
- 确定DLBCL的潜在预后生物标志物和治疗点.
主要方法:
- 对DLBCL组织中ACOT7表达的公共数据库的分析.
- 在DLBCL细胞系中使用ACOT7沉默的功能实验.
- 使用分子试验识别ACOT7的转录调节剂.
主要成果:
- ACOT7在DLBCL中表达很高,与患者预后不佳相关.
- 沉默ACOT7抑制DLBCL细胞的增殖,入侵和上皮细胞-介质细胞转变 (EMT) 基因表达,同时诱导细胞亡和细胞循环停止.
- 调节元素结合转录因子2 (SREBF2) 被确定为一种转录调节剂,可调节ACOT7,促进DLBCL进展.
结论:
- SREBF2-ACOT7轴对DLBCL瘤的生长,入侵和生存至关重要.
- ACOT7代表了DLBCL的潜在预后生物标志物和治疗标,为其侵略性提供了新的见解.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K


